Related Experiment Videos
[Antibiotic-associated diarrhea]
O Schröder1, R Gerhard, J Stein
1Medizinische Klinik I -- ZAFES, J.-W.-Goethe-Universität Frankfurt/Main.
Zeitschrift Fur Gastroenterologie
|February 4, 2006
Summary
Antibiotic-associated diarrhea (AAD) arises from gut microflora disruption. Probiotics and restrictive antibiotic policies can effectively reduce AAD incidence and severity.
Area of Science:
- Microbiology
- Gastroenterology
- Pharmacology
Context:
- Antibiotic-associated diarrhea (AAD) affects 15-25% of patients.
- AAD pathogenesis involves gut microflora dysbiosis, impacting carbohydrate and bile acid metabolism.
- Pathogenic proliferation, including Clostridium difficile and Klebsiella oxytoca, contributes to severe AAD forms.
Purpose:
- To review the causes, diagnosis, and management of antibiotic-associated diarrhea.
- To highlight the role of gut microbiota alterations in AAD development.
- To discuss therapeutic strategies and preventative measures for AAD.
Summary:
- AAD is primarily caused by antibiotic-induced gut microflora changes.
- Clostridium difficile and Klebsiella oxytoca are key pathogens in severe AAD.
- Diagnosis involves toxin detection and culture; metronidazole is first-line treatment, vancomycin for refractory cases.
- Saccharomyces boulardii probiotics and restrictive antibiotic policies can prevent AAD.
Impact:
- Informing clinical practice for AAD management and prevention.
- Guiding the development of targeted therapies and probiotic interventions.
- Reducing healthcare burden associated with antibiotic-associated diarrhea.